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INTRODUCTION
Proton magnetic resonance spectroscopy (1H MRS) is a
noninvasive technique that allows us to provide an in vivo
assessment of brain tissue composition and this gives us an
insight into the metabolic processes of neurologic disorders
(1, 2). This technique’s ability to obtain good spatial localiza-
tion and serial measurements with high resolution makes in
vivo 1H MRS an ideal investigative tool of brain function, with
respect to biochemical interactions (3). The application of
this technique creates the possibility of observing major brain
metabolites that contributes to the major resonances seen in
1H MR spectra of the brain, such as N-acetylaspartate (NAA),
creatine/phosphocreatine (Cr), choline-containing compounds
(Cho), and myo-inositiols (Ins) (1-3). Using current localiza-
tion techniques, 1H MRS spectra can be obtained from regions
of 1-10  L within the timescale of a clinical examination, and
this allows for the definition of spectral changes specific to
the motor cortex (3).
Early studies of 1H MRS in stroke have mostly investigated
ischemic stroke, and they have shown an increased lactate and
decreased NAA within the stroke lesion (4-6). However, at-
tempts to determine whether the magnitude of neuronal dam-
age, as measured by NAA loss, correlates with the disability
and impairment in ischemic stroke patients have brought
forth inconsistent results (7-10). There has been no previous
1H MRS study that has investigated the metabolic changes
in the higher motor cortex following intracerebral hematoma
in hemiparetic humans. The aim of this study was to evaluate
the local metabolic changes for the primary motor cortex (M-1)
and supplementary motor area (SMA) in the affected hemi-
sphere (AH) and unaffected hemisphere (UH), according to
their axonal injuries at the level of the internal capsule.
MATERIALS AND METHODS
Study participants
The M-1/SMA of the AH and the UH were studied using
1H MRS on 9 patients (4 men and 5 women; mean age 54 yr,
range 30-70 yr, right-handed) with documentable hemipare-
sis of varying severity. The patients’ clinical details are sum-
marized in Table 1. In all cases, the hemiparesis was caused
by deep intracerebral hematoma in the putamen and the tha-
lamus because these locations are directly adjacent to the in-
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Proton Magnetic Resonance Spectroscopic Changes of the Primary
Motor Cortex and Supplementary Motor Area in Hemiparetic Patients
with Corticospinal Tract Injury due to Deep Intracerebral Hematoma
This study was conducted to investigate the metabolic changes in the motor and
motor association cortices following axonal injury in the internal capsule that was
caused by deep intracerebral hematoma. Using proton magnetic resonance spec-
troscopy (
1H MRS), the authors studied the primary motor cortices (M-1) and sup-
plementary motor areas (SMA) of 9 hemiparetic patients with documentable hemi-
paresis of varying severity, and we studied 10 normal volunteers as controls. To
measure the M-1 and SMA biochemical changes, 4 separate single volumes of inter-
est (VOIs) were located bilaterally in the affected and unaffected hemisphere (AH
and UH). 
1H MRS provided a neuronal and axonal viability index by measuring levels
of N-acetylaspartate (NAA) and creatine/phosphocreatine (Cr). The M-1/SMA NAA/Cr
ratios of the AH and UH in patients, and the AH and normal volunteers were com-
pared. The NAA/Cr ratios of the M-1 and SMA in AH, and the SMA in UH were sig-
nificantly lower than those of normal volunteers. These 
1H MRS findings indicate
that axonal injury in the descending motor pathway at the level of internal capsule
could induce metabolic changes in the higher centers of the motor pathway.
Key Words : Hemiparesis; Paresis; Cerebral Hemorrhage; Magnetic Resonance Spectroscopy; Motor Cor-
tex; Internal Capsule; N-acetylaspartate
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ternal capsule, and an intracerebral hematoma in these areas
mostly brings about hemiparesis as a neurologic sequele. Neu-
rosurgical inpatients and outpatients were recruited for the
study. The 1H MRS study was performed on alert patients
with definite hemiparesis of the extremities contralateral to
the AH. To control the possible 1H MRS spectral change, we
excluded those patients that had undergone any surgical inter-
vention or if they had a major systemic illness, such as uremia.
The results were compared with 1H MRS studies performed
on 10 normal control volunteers (five men and five women;
mean age 41 yr, range 28-59 yr, all right-handed), and they
were screened to exclude those people with prior systemic
disease or head injury. The Institutional Review Board approv-
ed the MR study proctocol and the investigation was conduct-
ed in full compliance with accepted standards for research
involving humans. An informed consent was obtained from
all participants or their legal guardians. The mean duration
of the study was approximately 1 yr, with a range of 7 days
to 1 yr after development of intracerebral hematoma.
1H MRS procedures
In vivo 1H MRS studies were performed on a 1.5 T MRI/
MRS system (GE Signa Advantage, version 4.8; GE Medi-
cal Systems, Milwaukee, WI, U.S.A.) using the stimulated
echo acquisition mode (STEAM) sequence after water sup-
pression with chemical-shift selective (CHESS) RF pulse and
dephasing gradients (11, 12). A standard head coil was used
for the routine neurological and research imaging sequences,
with image-guided single-voxel spectroscopic acquisition.
A 6.4 mL volume in the cortex was selected using the T2-
weighted MR images (90 msec TE, 2,500 msec TR). For
examining the M-1 cortex with the single voxel technique,
a cubic volumes of interest (VOI) of 18×18×20 mm was
placed in the medial precentral gyrus (Broadman area 4) ante-
rior to the central sulcus in both hemispheres (AH and UH),
and for the SMA, the same-sized VOI was placed in the medial
side of the superior frontal gyrus (Broadman area 6) just ante-
rior to the M-1 cortex VOI, as is shown in Fig. 1. The voxel
location was carefully chosen by two investigators to ensure
the exact anatomical location of M-1/SMA for each patient.
The spectral parameters used were: 20 msec TE, 2,000
msec TR, 128 averages, 2,500 Hz spectral width, and 2,048
data points. The shim procedure was used for optimizing the
magnetic field homogeneity over the entire volume of inter-
est that was detected by the receiver coil and focused on the
water signal. After an autoprescan, the typical line width
(full length at half maximum; FWHM) was usually 2 to 4
Hz, and the raw data was processed using a SAGE data analy-
sis package (GE Medical Systems). The post-processing was
done using zerofilling to 4K, and apodization filtering was
used to improve either SNR or resolution and/or to reduce
the truncation artifacts. Fourier transformation, zero order
phase correction, and phase absorption spectra were performed
directly along with baseline corrections or resolution enhance-
ment. The peak areas were obtained from the spectra using
Case
No.
Age (yr)/
Sex
Location of ICH
Interval after
ictus
Degree of 
hemiparesis*
Arm Leg
1 53/m lt basal ganglia 6 m 4 4
2 80/f rt basal ganglia 12 m 4+ 4+
3 72/m lt thalamus 2 w 2 2
4 45/f rt basal ganglia 2 m 3 4+
5 30/f rt basal ganglia 2 w 1 1
6 56/m rt basal ganglia 2 w 1 3
7 45/f lt basal ganglia 1 w 4 4
8 52/m rt basal ganglia 3 w 3 3
9 50/f lt basal ganglia 2 w 4 5
Table 1. Demographic data on patient’s profile
ICH, intracerebral hematoma; ictus, onset of bleeding; rt, right; lt, left; m,
male; f, female; w, week; m, month. *Degree of hemiparesis, medical
research council grading system (31).
Fig. 1. Voxel site for magnetic resonance spectroscopy (MRS) acquisition in the primary motor cortex (M-1) and supplementary motor area
(SMA). (A) CT scan of a hemiparetic patient (Case 1). The intracerebral hematoma is in the left basal ganglia that is directly adjacent to
the internal capsule. (B) M-1 voxel. Axial T2-weighted MR image showing a typical site of MRS acquisition of the M-1 cortex (rectangles).
(C) SMA voxel. Axial T2-weighted MR image showing a typical site of MRS acquisition of the SMA cortex (rectangles).
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the Marquardt algorithm to fit a Lorentzian-Gaussian peak
type (13). Proton peak assignments of the major in vivo 1H
MRS observable metabolites were NAA at 2.00 ppm; Cr at
3.00 pm; Cho at 3.20 ppm; sum (Glx) of Glu and GABA
at 2.35, and 2.25 ppm; and Ins at 3.50 pm (14). After the
data was processed by our selected personal ‘‘blinded’’ to the
patient’s histories and conditions, the results were expressed
as means±SD of the NAA/Cr ratio and the Cho/Cr ratios.
Statistical Analysis
The metabolite ratios in the AH and UH and the controls’
values were compared for significant differences using the
paired t-test assuming equal variance and independent sam-
ple t-test. Probability values of less than 0.05 were considered
significant, and values less than 0.01 were considered highly
significant.
RESULTS
The results are summarized in Table 2. The NAA/Cr ratios
of M-1 in the AH and UH were 1.08±0.12, 1.50±0.17,
respectively. There were significant differences between the
AH and UH in the NAA/Cr ratios of M-1 (p<0.05). The
NAA/Cr ratios of M-1 measured in the AH and controls were
1.08±0.12, 1.37±0.12, respectively. There was also signif-
icant differences between the AH and controls in the NAA/Cr
ratios of M-1 (p=0.01). However, the NAA/Cr ratios of M-1
measured in the UH showed no differences when compared
with the ratios of normal volunteers (p=0.115). These results
showed that the NAA/Cr ratios of the AH were significantly
decreased when compared with those of the UH and normal
volunteers and therefore, the metabolic changes had occurred
in the high cortical region ipsilateral to the injured hemi-
spheres. However, the NAA/Cr ratios of M1 in the AH showed
no significant correlation with the severity of arm weakness,
leg weakness, or the duration of hemiparesis.
The NAA/Cr ratios of the SMA measured in the AH and
UH were 1.18±0.15, 1.18±0.27, respectively. There was
no difference between the AH and UH in the NAA/Cr ratios
of the SMA (p=0.980). However, when compared with the
SMA of the controls, the NAA/Cr ratios of SMA in the AH
and UH showed significant differences (p<0.05).
In terms of Cho/Cr ratios, no significant differences were
found between the following; the M1 cortices of the AH and
43210
ppm
NAA
Cho Cr
Fig. 2. Typical spectrum of proton magnetic resonance spectroscopy (
1H MRS) in the chosen voxel. Graph showing typical MRS spectra
obtained from the M-1 cortex in the affected and unaffected hemispheres (Case 1). All spectra were acquired using the STEAM technique;
20 msec TE, 2,000 msec TR, 128 averages, 2,500 Hz spectral width, and 2,048 data points.
(A) M-1 in affected hemisphere. (B) M-1 in unaffected hemisphere.
A
43210
ppm
NAA
Cho Cr
B
M-1
AH UH Control
SMA
AH UH Control
NAA/Cr* 1.08±0.12
� 1.50±0.17 1.37±0.12 1.18±0.15
� 1.18±0.27
� 1.40±9.151E-02
Cho/Cr* 0.85±0.21 1.66±2.17 0.85±5.638E-02 0.88±0.29 0.88±0.29 0.83±7.724E-02
Table 2. Comparison of metabolite ratios obtained by in vivo 
1H MRS
*Values are expressed as means±SD. 
�
shows significant differences when compared with control values (indepent sample t-test).
M-1, primary motor cortex; SMA, supplementary motor area; AH, affected hemisphere; UH, unaffected hemisphere; NAA, N-acetylaspartate; Cho, choline-
containing compounds; Cr, creatine/phosphocreatine.Metabolic Changes of Motor Cortex after Corticospinal Tract Injury 747
UH (p=0.316), the SMAs of the AH and UH (p=0.561), the
M-1 cortex and SMA of the AH (p=0.745), and the M-1 cor-
tex and SMA of the UH (p=0.289). No significant differences
were found when comparing the Cho/Cr ratios of each cortex
with those of the normal volunteers. The lactate resonance,
which we expected to see at 1.3 ppm, was not observed in
any of these cases. The NAA/Cr and Cho/Cr ratios of the M1
and SMA in the control group did not show any difference
between right and left hemispheres.
DISCUSSION
Hemiparesis is the most commonly experienced deficit after
stroke, and it acutely affects more than 80% of subjects and
chronically affects greater than 40% of the subjects (15). Pa-
tients show a wide range for the degree of recovery, and the
restorative processes that occur in the brain after stroke remain
incompletely understood. This work focused on the neuro-
chemical profile of the motor cortex and the supplementary
motor area in relation with pyramidal tract injury caused by
deep intracerebral hematoma.
1H MRS provides chemical information on the local cellular
metabolism by using the metabolic ratios of neurochemicals
detected in the spectra (11, 12). One of the most important
contributions of 1H MRS to clinical neuroscience is its ability
to quantify neuronal loss and to demonstrate reversible neu-
ronal damage (1, 2). 1H MRS is a useful research tool for elu-
cidating the pathophysiology underlying certain diseases, in-
cluding brain tumors, head trauma, cerebrovascular, neurode-
generative, and metabolic brain diseases (1).
1H MRS has been used in attempting better qualification
of the brain damage caused by stroke. 1H MRS allows the in
vivo measurement of N-acetyl-containing compounds, crea-
tine, choline, and lactate. The majority of the N-acetyl signal
comes from NAA, which is present in high concentrations
in the brain (16). The function of NAA is unclear, although
suggestions have included the initiation of protein synthesis,
neurotransmission, and the deactivation of glutamate. NAA
is of particular interest in studies of the brain because it is
located almost exclusively in the neurons of adults (17). Ini-
tially, it was suggested that decrease in NAA represented neu-
ronal loss (18); however, a reversible decrease in NAA has
recently been shown to occur for acute lesions in multiple
sclerosis and in stroke-like episodes of MELAS (19). Further,
NAA synthesis in vitro has been shown to occur in an ener-
gy-dependent manner, and this is reduced by mitochondrial
inhibitors (20). Therefore, decrease in the NAA resonance
peak in vivo must be interpreted as an index of neuronal or
axonal injury rather than as a marker of neuronal or axonal
loss (21). Decrease in NAA have been shown to correlate with
disability in multiple sclerosis (22), suggesting that axonal
injury is responsible for the chronic functional impairment
in this disease.
Early studies of 1H MRS for stroke have shown increased
lactate and decreased NAA within the stroke lesion (4-6). Sub-
sequent attempts have been made to determine whether the
magnitude of neuronal damage, as measured by the NAA loss
from the infarcted region, correlated with the disability and
impairment in stroke patients. Ford et al. (8) found that the
patients who made the most complete recoveries were those
in whom NAA levels were relatively well preserved. In con-
trast, Gideon et al. (9) found no clear relationship between the
level of NAA and the patient’s clinical outcome. Graham et al.
(10) found that NAA reduction correlated with the Barthel
index score at discharge. Federico et al. (7) found that the NAA
loss measured during the first week after stroke in patients
with a speech or motor deficit correlated with the Scandina-
vian Stroke Scale and the Barthel index at 6 months. 
However, some authors have criticized these findings be-
cause it remained unclear whether NAA loss was a better pro-
gnostic indicator than other measures, such as infarct volume
as measured on imaging (21). Pendlebury et al. (21) has point-
ed out that the above-mentioned studies regarding 1H MRS
and outcome after stroke measured the NAA loss from the
center of infarcted region, and thus these NAA losses were not
representative of the total neuronal injury. Moreover, the NAA
loss was not measured in a specific brain region directly relevant
to the chosen outcome measures. To examine the relationship
between NAA loss after stroke and motor outcome, the re-
searchers studied NAA levels in the posterior limb of the in-
ternal capsule, which contains the descending motor pathways
for patients with motor deficits secondary to a cortical, subcor-
tical, or capsular stroke. In that study, they found that mean
internal capsule NAA was significantly lower in the patient
group and axonal injury in the descending motor pathways
at the level of internal capsule correlated with motor deficit
for patients after stroke. They suggested a possible anterograde
axonal injury might have an important role for this NAA loss
in strokes involving the internal capsule and the motor and
subcortex areas that contains the motor pathway (21).
Although there have been many 1H MRS studies dealing
motor deficit in ischemic stroke, 1H MRS studies investigat-
ing the motor system in hemorrhagic stroke, especially in the
intracerebral hematoma, are rare. Furthermore, only a few
researchers have used 1H MRS for the detection of biochem-
ical changes in the motor and motor association areas follow-
ing the subordinate motor pathway damage (3, 23).
The biochemical information obtained during the present
study shows that the M-1 NAA/Cr ratios are significantly
decreased in the AH for intracerebral hematoma, which in-
duces axonal injury to the internal capsule. The exact patho-
physiologic mechanism of NAA loss in the normal-appearing
motor cortex is unclear. However, reduced levels of NAA in
normal-appearing white matter have already been shown to
occur in those patients with multiple sclerosis and cerebral
ischemia that has caused motor stroke (21, 24). We suggest
that NAA loss in the M-1 in our present study may be caused748 D.J. Yang, B.C. Son, H.-M. Baik, et al.
by a retrograde degeneration according to the axonal injury
at the level of internal capsule, and this is due to adjacent in-
tracerebral hematoma. Pendlebury et al. (21) studied eighteen
ischemic strokes that caused motor deficit with the use of
1H MRS, and they have shown that cortical and subcortical
stroke induced NAA loss in the normal-appearing internal
capsule. They explained this NAA loss in the internal capsule
for the anterograde degeneration. The metabolic information
obtained in our study shows that the NAA/Cr ratios in the
M-1 are significantly decreased in the AH following an intrac-
erebral hematoma. Although the examination time and the
time associated with the disease are quite different, with respect
to neural injury (i.e. the motor pathway), it is believed that
there likely is a significant commonality between the two. 
Reduced metabolism in the motor cortex has already been
documented in a PET study dealing the ischemic stroke (25).
In a PET study of 10 patients following recovery from stria-
tocapsular infarction, the comparison of regional cerebral
blood flow (rCBF) maps for patients at rest and normal sub-
jects revealed the significantly lower regional cerebral blood
flow in the basal ganglia, thalamus, sensorimotor, insular,
and dorsolateral prefrontal cortices, in the brainstem, and in
the ipsilateral cerebellum in patients, contralateral to the side
of the recovered hand (25). These researchers suggest that the
cause of decreased rCBF in these areas as a functional deacti-
vation, although structural changes at a microscopic level due
to transsynaptic or retrograde degeneration cannot be exclud-
ed. The reduction of the NAA/Cr ratios in the M-1 cortex in
our study seems to be concordant with the already document-
ed reduction of rCBF in the sensorimotor cortex by the PET
study of recovered ischemic capsular infarction (25).
Puri et al. (3), evaluated the motor cortex by using in vivo
1H MRS in patients with incomplete spinal cord injury who
showed a good motor function recovery. In that report, the
mean level of the NAA/Cr ratio was significantly elevated in
the motor cortex of patients, as compared with their ipsilat-
eral occipital cortex or the cortical area of controls. They ex-
plained this increased NAA/Cr value as a neural adaptation,
which accompanies recovery from spinal cord injury. At first
glance, this increased NAA/Cr value in the motor cortex of
the recovered incomplete spinal cord injury study seems to
be contrary to our observations of decreased NAA/Cr values
in the AH motor cortex with hemiparesis. However, there are
several differences in the patients’ characteristics, the methods
used for MRS, location of voxels, etc. In a study by Puri et al.
(3) the subjects were those who had already had shown good
recovery of their motor function after neural injury, but we
enrolled subjects who had not recovered from hemiparesis.
In terms of the technical aspects of 1H MRS, Puri and his
co-workers located the voxel in the centrum semiovale, and
they used the technique of chemical shift imaging.
We found no significant correlation between the severity
of weakness and the NAA/Cr values in the M-1, and we be-
lieve that the functional location of the voxel in our study was
closer to the trunk and leg homunculus than the arm homuncu-
lus. Nevertheless, no correlation was found between the NAA/
Cr values in the affected M-1 and the severity of leg weakness.
However, we think it is difficult to draw a definite conclusion
with our results because the number of patients enrolled in
our study was so small and timing of the 1H MRS examina-
tion after the development of intracerebral hematoma was
variable. At this time, it is not clear whether the NAA/Cr ratio
of the AH would increase according to the recovery from hemi-
paresis in intracerebral hematoma. There is evidence that a sig-
nificant recovery of NAA can occur after acute brain damage
(19). For example, reversible decreases in NAA were found in
two patients with mitochondrial encephalopathy and four pa-
tients with demyelinating lesions (24). Further study will be
needed with a longer follow-up and larger numbers of subjects
to investigate the correlation with the severity of weakness.
The SMA (M-II) occupies the medial surface of the supe-
rior frontal gyrus rostral to area 4, and this corresponds to the
medial part of area 6 (area 6 ) (26). The SMA is considered
to be involved in the programming of learned skilled motor
sequences and it may play a role in initiating voluntary move-
ment (27). The recruitment of the SMA has been described
as a normal accompaniment to either the anticipation or se-
quencing of a motor task (28). Clinical studies suggest that
the SMA may contribute to the return of motor function after
stroke (29, 30). Therefore, to investigate whether there is any
biochemical alteration due to capsular injury in intracerebral
hematoma, we included the bilateral SMA in addition to the
M-1 in our study. In our present study, we found a significant
reduction of the NAA/Cr ratios in both the AH and UH, as
compared with the normal controls. It is difficult to explain
the exact meaning of this reduction of NAA/Cr ratio in the
bilateral SMAs. However, the SMA have striking bilateral
influences upon both proximal and distal musculatures in
primates, and cortical projections from the SMA are ipsilat-
eral to areas 4-6, and 7, and to the contralateral SMA (26-28).
Considering that the SMA has bilateral influence on motor
function, we speculate that unilateral injury to the motor
pathway might induce metabolic changes in the bilateral
SMA by a possible retrograde degeneration.
In summary, we sought to determine whether 1H MRS is
able to detect the metabolic changes of the M-1 and SMA
that follow pyramidal tract injury after intracerebral hemor-
rhage. We found that the M-1 in the AH has lower NAA/Cr
values than in the M-1 in the UH and in normal volunteers.
In addition, the SMA also showed bilateral lower NAA/Cr
values in both the AH and UH than in normal volunteers.
Though we cannot precisely document the exact meaning of
these lower NAA/Cr ratios, a presumed retrograde degener-
ation or functional deactivation may play a role in these NAA
losses in M-1 and SMA due to motor tract injury. Further
experiments should include longitudinal studies of patients
with motor deficit after intracerebral hematomas, and whether
there is a reversible component to this NAA loss.Metabolic Changes of Motor Cortex after Corticospinal Tract Injury 749
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